💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for BioMarin Pharmaceutical Inc. (BMRN)
« Back to company indexBMRN Chatter Timeline
Stock Ticker for BMRN
Most Active Tweeters for BMRN
| User | Tweets |
|---|---|
| @sleekoptions | 8 |
| @StockTexts | 5 |
| @newsfilterio | 5 |
| @fintel_io | 5 |
| @FlashAlert_me | 4 |
Recent Tweets for BMRN
 |
@newsfilterio $120.16 of shares acquired by Meier Richard A (Director), reported in a new form 4 filed with the SEC $BMRN https://t.co/mDxLhsfmRR May 8th 2021, 3:05pm |
 |
@InsiderAlerts4U $BMRN: New Insider Filing on BIOMARIN PHARMACEUTICAL INC's Director RICHARD A MEIER: https://t.co/7WGpFpd07N May 8th 2021, 12:05am |
 |
@insiderbuyings $BMRN new insider selling: 5068 shares. https://t.co/giqmnWLNHW May 7th 2021, 11:05pm |
 |
@StockTexts $BMRN BioMarin Pharmaceutical Inc. SEC Filing: Form 4 https://t.co/YAtdfcPpJY May 7th 2021, 11:05pm |
 |
@fintel_io Insider Richard A Meier reports selling 5,068 shares of $BMRN for a total cost of $397,245.04 https://t.co/vL5Q72L2fo May 7th 2021, 11:05pm |
 |
@dailycandlestix $BMRN Bearish Engulfing Daily appearances since 2010: 134 Close 5 days later ±: Avg: -0.23 SD: 5.09 Worst: -42.02 B… https://t.co/MhVBXwwxmv May 7th 2021, 8:05pm |
|
@dailycandlestix $BMRN Below Avg Volume Daily appearances since 2010: 302 Close 5 days later ±: Avg: -0.11 SD: 3.66 Worst: -46.49 Be… https://t.co/lC1yURcOTW May 7th 2021, 8:05pm |
|
@InsiderAlerts4U $BMRN: New Insider Filing on BIOMARIN PHARMACEUTICAL INC's EVP, Chief Technical Officer CHARLES GREG GUYER: https://t.co/4nfiiYmZGx May 6th 2021, 2:05pm |
 |
@Ba4Saso $BMRN waiting for buy signal https://t.co/QujLdlKdrZ May 6th 2021, 12:05pm |
|
@StockTexts $BMRN BioMarin Pharmaceutical Inc. SEC Filing: Form 4 https://t.co/akmGdOk59c May 6th 2021, 1:05am |
 |
@1stOncology #BioMarin to Participate in Two Upcoming Virtual #InvestorConferences $BMRN https://t.co/14Bq37fnHz May 5th 2021, 9:05am |
|
@insiderbuyings $BMRN new insider selling: 4673 shares. https://t.co/giqmnWLNHW May 5th 2021, 5:05am |
 |
@mattyjc @ArlingtonResea1 @_B_I_O_T_E_C_H_ In short, $BMRN lost the clear lead in Heme A. And if even if they are first to m… https://t.co/lBsQK1w5xo May 5th 2021, 1:05am |
|
@mattyjc @ArlingtonResea1 @_B_I_O_T_E_C_H_ I believe he was referring to FDA CRL to $BMRN’s NDA and accompanying requirement… https://t.co/XVMCtyywFI May 5th 2021, 1:05am |
|
@StockTexts $BMRN BioMarin Pharmaceutical Inc. SEC Filing: Form 4 https://t.co/0AEev8DBi5 May 5th 2021, 12:05am |
|
@fintel_io Insider George Eric Davis reports selling 4,673 shares of $BMRN for a total cost of $365,895.90 https://t.co/l87AelVtr5 May 5th 2021, 12:05am |
 |
@formwhisperscom #FWSells $BMRN Davis George Eric, EVP, General Counsel of BIOMARIN PHARMACEUTICAL INC sold 4,673 shares on 2021-05-… https://t.co/md52hdlMzc May 5th 2021, 12:05am |
|
@dailycandlestix $BMRN Hanging Man Daily appearances since 2010: 39 Close 5 days later ±: Avg: 0.03 SD: 3.45 Worst: -6.40 Best: 10.7… https://t.co/eW3OElk7tW May 4th 2021, 8:05pm |
 |
@TradeWithAlerts Nice Print for $BMRN - Amount: $9,384,292.90 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 4th 2021, 8:05pm |
 |
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: @mattyjc meanwhile at $BMRN HQ https://t.co/WJErortUTu May 4th 2021, 5:05pm |
|
@_B_I_O_T_E_C_H_ @mattyjc meanwhile at $BMRN HQ https://t.co/WJErortUTu May 4th 2021, 4:05pm |
|
@Ba4Saso $BMRN waiting for buy signal https://t.co/83GOoxNuEn May 4th 2021, 1:05pm |
|
@InsiderAlerts4U $BMRN: New Insider Filing on BIOMARIN PHARMACEUTICAL INC's Chief Executive Officer JEAN JACQUES BIENAIME: https://t.co/cHNfS5LHPJ May 4th 2021, 6:05am |
|
@StockTexts $BMRN BioMarin Pharmaceutical Inc. SEC Filing: Form 4 https://t.co/1hK4Nr1xII May 4th 2021, 12:05am |
 |
@FlashAlert_me $BMRN [15s. delayed] filed SEC form 4: Chief Executive Officer BIENAIME JEAN JACQUES: Converted securities 1,000 o… https://t.co/q2MwTfEggS May 4th 2021, 12:05am |
 |
@KingsSaddle $BMRN BioMarin to Participate in Two Upcoming Virtual Investor Conferences #Tradeshow #News https://t.co/t9HNsAdTcD May 3rd 2021, 3:05pm |
 |
@stock_titan $BMRN BioMarin to Participate in Two Upcoming Virtual Investor Conferences https://t.co/qT2iBC5zuS May 3rd 2021, 12:05pm |
 |
@DEANSTA1873 RT @TerraPharma1: Cont. re:Australia. $NVTA expanding team there and recently co-presented in Australia with Biomarin $BMRN https://t.co/M7… May 2nd 2021, 7:05pm |
 |
@sleekoptions Peak profit for the last 6 expired option alerts for $BMRN 11.11% | 39.13% | -93.33% | 7.46% | 76.67% | 17.65% |… https://t.co/KGz7tBEpTK May 2nd 2021, 4:05pm |
|
@sleekoptions $BMRN [May-21 75.00 Puts] Option volume Up +374.40% | Volume: 1,390 vs 293| May 2nd 2021, 4:05pm |
|
@sleekoptions $BMRN - Last six months, 8 option alerts peaked above 100% after they were triggered by the algo… https://t.co/sWkRyT9S9U May 2nd 2021, 4:05pm |
|
@sleekoptions $BMRN - View historical options performance for BMRN https://t.co/ftqgCzlD5G https://t.co/Jrt5K6YdHE May 2nd 2021, 4:05pm |
|
@Ba4Saso $BMRN waiting for short signal https://t.co/WF9v8esKZJ May 2nd 2021, 2:05pm |
 |
@Gambiste1 RT @CSIMarket: $BMRN #StockMarket #BiomarinPharmaceutical released fiscal period ending Mar 31 2021 Results on https://t.co/savSNTKlN1: Loo… May 2nd 2021, 6:05am |
 |
@CSIMarket $BMRN #StockMarket #BiomarinPharmaceutical released fiscal period ending Mar 31 2021 Results on… https://t.co/iNff5QWVqh May 2nd 2021, 5:05am |
|
@newsfilterio Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $BMRN https://t.co/XwtBuWkOwA May 1st 2021, 6:05pm |
 |
@EdgarInsider SEC Form 10-Q [Quarterly Report] filed by $BMRN BIOMARIN PHARMACEUTICAL INC https://t.co/2Ws4fPBGon April 30th 2021, 6:04pm |
|
@fintel_io $BMRN / BioMarin Pharmaceutical files form 10-Q https://t.co/eI2gmkEdJd April 30th 2021, 6:04pm |
|
@FlashAlert_me $BMRN [15s. delayed] filed form 10-Q on April 30, 14:10:27 https://t.co/qtyD1Vfn08 April 30th 2021, 6:04pm |
|
@Gambiste1 RT @Quantumup1: BofA increasingly +ve on $BMRN as approaches the launches of Voxzogo/Roctavian, sees upcoming 5Y/4Y P1/2 Roctavian data and… April 30th 2021, 3:04pm |
 |
@Quantumup1 BofA increasingly +ve on $BMRN as approaches the launches of Voxzogo/Roctavian, sees upcoming 5Y/4Y P1/2 Roctavian… https://t.co/5RYPeLiFta April 30th 2021, 3:04pm |
|
@Quantumup1 Wedbush $BMRN Outperform~$139 PT Notes In June BioMarin anticipates a CHMP opinion on the MAA for vosoritide to tre… https://t.co/wchXVInz23 April 30th 2021, 2:04pm |
 |
@ResearchPool $BMRN #BioMarin Pharmaceutical Inc. Q1 Financials, Pipeline Progress and Vosoritide/ACH PDUFA Update: [...]… https://t.co/RgoGAnMAr4 April 30th 2021, 2:04pm |
 |
@sbwcws BioMarin's Q1 revenue was better than expected, says Wedbush $BMRN April 30th 2021, 2:04pm |
 |
@MauriceOnTW @_B_I_O_T_E_C_H_ @VelocirapmTOR Perhaps $BMRN learned its lesson and is keeping coy about things. I don't know why… https://t.co/DRP2DNZIL0 April 30th 2021, 2:04pm |
|
@_B_I_O_T_E_C_H_ @VelocirapmTOR @MauriceOnTW For roctavian in Hem A, $BMRN biomarin noted that FDA reiterated their recommendation f… https://t.co/YvTZsJGINP April 30th 2021, 2:04pm |
 |
@fda_tracker $BMRN New PDUFA Date 2021-11-20 BioMarin Pharmaceutical Inc. Link:https://t.co/iKnXlczFci Calendar:https://t.co/sCt1qKoMdr April 30th 2021, 1:04pm |
 |
@OpenOutcrier $BMRN (-3.3% pre) BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings and Revenue Estimates https://t.co/FMXJup0gj0 April 30th 2021, 12:04pm |
|
@newsfilterio BioMarin Announces First Quarter 2021 Financial Results and Corporate Updates $BMRN https://t.co/BUw9hcApxj April 30th 2021, 7:04am |
 |
@earningsinfo $BMRN Q1 2021 Earnings Call https://t.co/RoQpOQHEZA April 30th 2021, 5:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
